This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures.
Building
B
Industry
Biotech
Employees
13
Founding year
2020
This website uses cookies. Read our data privacy statement to find out how we use cookies and how you can change your settings.
Home 
About us 
Offer 
News 
Financial support for start-ups in Basel 
Media 
Contact